Whether the presence of this hormone is detectable in a standard drug screening is a frequent concern. The answer depends on several factors, most notably the type of test conducted and the specific substances being investigated. Routine drug panels typically focus on illicit substances or commonly abused prescription medications, and are not designed to identify variations in endogenous hormone levels.
The detection of exogenous administration or supraphysiological levels carries implications in sports, employment, and legal contexts. Athletes are often subjected to testing to ensure fair play, while certain professions require assurance of unimpaired judgment and physical ability. Historically, methods to detect such substances have evolved considerably, driven by advancements in analytical chemistry and a growing awareness of performance-enhancing drugs.